Summit Therapeutics Inc.
SMMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$221,315 | -$614,928 | -$78,782 | -$88,602 |
| Dep. & Amort. | $89 | $2,050 | $2,514 | $2,455 |
| Deferred Tax | $0 | $0 | $0 | $326 |
| Stock-Based Comp. | $50,981 | $14,108 | $9,884 | $9,468 |
| Change in WC | $15,479 | -$2,368 | $8,616 | -$67 |
| Other Non-Cash | $12,660 | $524,378 | $14,122 | $497 |
| Operating Cash Flow | -$142,106 | -$76,760 | -$41,582 | -$72,587 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$139 | -$128 | -$624 | -$306 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$680,032 | -$321,022 | $0 | $0 |
| Inv. Sales/Matur. | $489,837 | $208,165 | $0 | $0 |
| Other Inv. Act. | -$15,007 | -$474,789 | -$1 | $0 |
| Investing Cash Flow | -$205,341 | -$587,774 | -$624 | -$306 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$100,000 | -$24,686 | $520,000 | $0 |
| Stock Issued | $477,893 | $5,000 | $100,000 | $75,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,334 | $106,199 | $100,244 | $2,916 |
| Financing Cash Flow | $381,227 | $86,513 | $620,244 | $77,916 |
| Forex Effect | -$18 | $839 | -$1,222 | $351 |
| Net Chg. in Cash | $33,762 | -$577,182 | $576,816 | $5,374 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71,425 | $648,607 | $71,791 | $66,417 |
| End Cash | $105,187 | $71,425 | $648,607 | $71,791 |
| Free Cash Flow | -$142,245 | -$76,888 | -$42,206 | -$72,893 |